ANGO Stock Recent News Angiodynamics (ANGO) 16.82 11/14/2014

New Post Public Reply Private Reply Replies (0) Message Board

Nov 14, 2014 at 11:13 PM

Angiodynamics (ANGO) 16.82 $ANGO

AngioDynamics gets Warning Letter
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 7:09PM CST

ANGO: 16.82 (-0.04)

Varian Medical (VAR) Down to Strong Sell on Dismal Q3 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 2:20PM CST
On Nov 14, 2014, Zacks Investment Research downgraded Varian Medical Systems (VAR) to a Zacks Rank #5 (Strong Sell).
ABMD: 33.25 (-0.23), VAR: 87.58 (-1.10), EW: 124.50 (-0.05), ANGO: 16.82 (-0.04)

Thoratec (THOR) Down to Strong Sell on Growing Headwinds - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 12:20PM CST
On Nov 11, 2014, Zacks Investment Research downgraded Thoratec Corp. (THOR) to a Zacks Rank #5 (Strong Sell).
ABMD: 33.25 (-0.23), EW: 124.50 (-0.05), THOR: 29.80 (+1.40), ANGO: 16.82 (-0.04)

Abiomed (ABMD) Hits 52-Week High on Strong Q2 Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 10:10AM CST
Shares of Abiomed, Inc. (ABMD) have been on the rise since it reported impressive second-quarter fiscal 2015 (ended Sep 30, 2014) results on Oct 30.
ABMD: 33.25 (-0.23), FLDM: 29.99 (+0.11), GMED: 22.74 (-0.18), ANGO: 16.82 (-0.04)

Mettler-Toledo (MTD) Tops Q3 Earnings on Revenue Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 8:34AM CST
Mettler-Toledo International Inc. (MTD) reported adjusted earnings per share (EPS) of $2.95 for the third quarter of fiscal 2014, which beat the Zacks Consensus Estimate of $2.86. Adjusted EPS also improved 13% from the year-ago quarter.
ABMD: 33.25 (-0.23), FLDM: 29.99 (+0.11), ANGO: 16.82 (-0.04), MTD: 288.27 (-1.76)

Roka Bioscience (ROKA) in Focus: Stock Surges 19.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 8:11AM CST
Roka Bioscience, Inc. (ROKA) was a big mover last session, as the company saw its shares rise over 19% on the day.
ABMD: 33.25 (-0.23), ROKA: 3.60 (+0.05), EW: 124.50 (-0.05), ANGO: 16.82 (-0.04)

AngioDynamics to Present at Upcoming Investor Conferences
GlobeNewswire - Tue Nov 11, 5:30AM CST
AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today the company will present at the following investor conferences in November:
ANGO: 16.82 (-0.04)

Volcano Posts Narrower-than-Expected Q3 Loss, Guides Low - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 10:10AM CST
Despite Volcano (VOLC) provided disappointing revenue guidance for 2014 on account of expected negative foreign exchange impact, management expects accelerated profitability over the near term.
ABMD: 33.25 (-0.23), VOLC: 10.92 (+0.13), EW: 124.50 (-0.05), ANGO: 16.82 (-0.04)

Strength Seen in DexCom (DXCM): Stocks Gains 14.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 8:46AM CST
DexCom (DXCM) was a big mover last session, with shares rising over 14% on the day.
ABMD: 33.25 (-0.23), DXCM: 52.73 (-0.90), EW: 124.50 (-0.05), ANGO: 16.82 (-0.04)

Hologic Beats Q4 Earnings, Sales as All Segments Gain - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 1:50PM CST
Hologic (HOLX) entered into an amended license agreement with Roka Bioscience, which earned a one-time revenue benefit of $20.1 million for Hologic
ABMD: 33.25 (-0.23), DXCM: 52.73 (-0.90), ANGO: 16.82 (-0.04), HOLX: 26.30 (-0.22)

Thoratec Q3 Earnings & Revenues Lag Estimates, Down Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 9:00AM CST
Following the earnings release, shares of Thoratec Corp. (THOR) declined approximately 3.5% to close at $26.10 yesterday.
ABMD: 33.25 (-0.23), CYNO: 27.38 (+0.18), THOR: 29.80 (+1.40), ANGO: 16.82 (-0.04)

Foundation Medicine Slumps: FMI Tumbles 9.6% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 7:59AM CST
Foundation Medicine has been witnessing a flat trend in its current year earnings estimate and its share price has been falling for past 24 hours
ABMD: 33.25 (-0.23), DXCM: 52.73 (-0.90), FMI: 24.68 (-0.27), ANGO: 16.82 (-0.04)

Teleflex Beats on Q3 Earnings & Revenues, Outlook Raised - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 1:20PM CST
Teleflex Inc (TFX) reported adjusted earnings of $1.57 per share which outshined both the Zacks Consensus Estimate of $1.37 and year-ago earnings of $1.33.
CYNO: 27.38 (+0.18), FLDM: 29.99 (+0.11), TFX: 114.83 (+0.19), ANGO: 16.82 (-0.04)

Symmetry Medical Q3 Earnings & Revenues Miss, Rise Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 1:10PM CST
Symmetry Medical Inc. (SMA) reported adjusted earnings per share of 11 cents in the third quarter of fiscal 2014, which missed the Zacks Consensus Estimates of 14 cents.
SMA: 9.44 (-0.04), CYNO: 27.38 (+0.18), FLDM: 29.99 (+0.11), ANGO: 16.82 (-0.04)

CryoLife Q3 Earnings Fall, Revenues Rise Y/Y; Shares Tank - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 1:00PM CST
CryoLife Inc. (CRY) reported adjusted earnings per share of 8 cents in the third quarter of fiscal 2014, lower than the year-ago earnings of 11 cents.
CYNO: 27.38 (+0.18), FLDM: 29.99 (+0.11), CRY: 9.68 (-0.06), ANGO: 16.82 (-0.04)

Mindray Medical Q3 Earnings in Line, 2014 View Lowered - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 2:07PM CST
Mindray Medical International Limited (MR) slashed its 2014 financial guidance in the face of increasing uncertainties in currency and other macro developments that could impact its performance in certain key markets.
ABMD: 33.25 (-0.23), FLDM: 29.99 (+0.11), ANGO: 16.82 (-0.04), MR: 31.06 (-0.16)

Techne Corp. (TECH) Q1 Earnings, Revenues Miss Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 12:50PM CST
Techne Corp. (TECH) reported adjusted earnings of 85 cents per share in the first quarter fiscal 2015, which was lower than the Zacks Consensus Estimate of 87 cents.
CYNO: 27.38 (+0.18), FLDM: 29.99 (+0.11), TECH: 90.64 (-1.46), ANGO: 16.82 (-0.04)

Abiomed Tops Q2 Earnings, Revenues; FY15 Sales View Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 12:10PM CST
Abiomed Inc. (ABMD) reported second-quarter fiscal 2015 earnings of 9 cents per share, outshining the Zacks Consensus Estimate of 2 cents.
ABMD: 33.25 (-0.23), FLDM: 29.99 (+0.11), BEAT: 8.17 (unch), ANGO: 16.82 (-0.04)

Becton, Dickinson (BDX) Beats Q4 Earnings, Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 11:03AM CST
Becton, Dickinson and Company (BDX) reported fourth-quarter fiscal 2014 earnings of $1.68 per share, which beat the Zacks Consensus Estimate by 3 cents.
BDX: 129.20 (-0.11), FLDM: 29.99 (+0.11), BEAT: 8.17 (unch), ANGO: 16.82 (-0.04)

Accuray (ARAY) Q1 Loss Wider Than Expected, Revenues Lag - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 12:30PM CST
Accuray Inc (ARAY) reported a loss of 28 cents per share in the first quarter of fiscal 2015, wider than the Zacks Consensus Estimate of a loss of 13 cents and a year-ago loss of 21 cents.
ATEC: 1.40 (+0.04), CYNO: 27.38 (+0.18), ARAY: 7.02 (-0.05), ANGO: 16.82 (-0.04)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Firefox Champions Privacy with Iconic Internet Campaign

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

D-Wave Investors Must Decide by Dec 15 Class Suit

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Love Business Group Helps SMEs Navigate Broadband Choices

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Sinclair Faces Labor Lawsuit for Break-time Violations

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Tennessee's Bold Lung Cancer Trial Signals Innovation

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Community in Shock After Fatal Bakersfield Shooting

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...